Ovarian Carcinoma
Radiotherapy resulted in a lower number of recurrences of ovarian cancer
Published in Women's Health Weekly, August 21st, 2003
According to a study from Sweden, "In a prospective randomized trial, consolidation treatment with radiotherapy or chemotherapy was compared with no treatment in a series of 172 patients with epithelial ovarian carcinoma, FIGO stage III, with complete surgical remission after primary cytoreductive surgery and induction chemotherapy.
"In the subgroup with complete surgical and pathologic remission, progression-free survival was significantly (p=.032) better in the radiotherapy group (56% at 5 years) than in the chemotherapy group (36% at 5 years) and the untreated control group...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Heart Disease Risk Factor
Insulin resistance prime suspect for heart risk in polycystic ovary syndrome - Hormone Replacement Therapy
Estrogen replacement increases risk factors for arrhythmia and sudden death - Bacterial Vaginosis
BV a strong risk factor for preterm delivery, miscarriage in early pregnancy - Breast Cancer
Gene test could reduce unnecessary treatment - Hysterectomy
Vaginal surgery suitable for most cases thought contraindicated for approach - Angiology
Gender differences seen in urocortin-induced vasorelaxation - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
